10
Feb
Noida (Uttar Pradesh) [India], February 10: Genient, a Noida-based genomics and molecular diagnostics company founded in 2017, is strengthening India’s precision healthcare ecosystem by delivering platform-agnostic, India-relevant molecular and next-generation sequencing (NGS) solutions tailored to the country’s real disease burden, including infectious diseases, antimicrobial resistance (AMR), oncology, and epigenetics. With India facing a high prevalence of tuberculosis, viral hepatitis, HIV, sepsis, and rising antimicrobial resistance, Genient’s clinical genomics portfolio is designed to support accurate diagnosis, drug-resistance profiling, and surveillance needs across hospitals, reference laboratories, and research institutions. The company offers comprehensive NGS-based drug resistance testing for infectious diseases such as HIV,…
